Piramal Pharma Limited (PPLPHARMA.BO)
INR 221.45
(2.07%)
INR 221.45
(2.07%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 42.27 Billion INR | -22.31% |
| 2022 | 54.41 Billion INR | 39.53% |
| 2021 | 38.99 Billion INR | 14065.71% |
| 2020 | 275.3 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 43.72 Billion INR | 0.0% |
| 2023 FY | 42.27 Billion INR | -22.31% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 42.82 Billion INR | 0.0% |
| 2023 Q4 | 42.27 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q2 | 46.2 Billion INR | 0.0% |
| 2022 FY | 54.41 Billion INR | 39.53% |
| 2022 Q4 | 54.41 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q4 | 38.99 Billion INR | 0.0% |
| 2021 FY | 38.99 Billion INR | 14065.71% |
| 2020 FY | 275.3 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 3.86 Billion INR | -993.562% |
| Aurobindo Pharma Limited | 3.69 Billion INR | -1044.667% |
| Glenmark Life Sciences Limited | -2.84 Billion INR | 1587.199% |
| Granules India Limited | 9.28 Billion INR | -355.227% |
| Indoco Remedies Limited | 6.47 Billion INR | -552.78% |
| Achyut Healthcare Limited | -3.74 Million INR | 1128663.801% |
| Ajanta Pharma Limited | -954.9 Million INR | 4527.27% |
| Alkem Laboratories Limited | -1.6 Billion INR | 2726.817% |
| Alpa Laboratories Limited | 35.36 Million INR | -119448.681% |
| Brooks Laboratories Limited | 49.48 Million INR | -85331.949% |
| AstraZeneca Pharma India Limited | -5.01 Billion INR | 943.421% |
| Bajaj HealthCare Limited | 3.29 Billion INR | -1181.497% |
| Bliss GVS Pharma Limited | -1.15 Billion INR | 3751.559% |
| Dr. Reddy's Laboratories Limited | 12.91 Billion INR | -227.391% |
| Eris Lifesciences Limited | 13.8 Billion INR | -206.206% |
| FDC Limited | -57.75 Million INR | 73302.66% |
| Glenmark Pharmaceuticals Limited | -4.28 Billion INR | 1086.545% |
| Gufic Biosciences Limited | 3.19 Billion INR | -1223.475% |
| Ind-Swift Laboratories Limited | -4.15 Billion INR | 1117.949% |
| Ipca Laboratories Limited | 11.41 Billion INR | -270.348% |
| Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | 3141.592% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -2087.156% |
| Lasa Supergenerics Limited | 205.79 Million INR | -20442.374% |
| Laurus Labs Limited | 24.38 Billion INR | -73.372% |
| Lupin Limited | 17.19 Billion INR | -145.901% |
| Mankind Pharma Limited | -9.9 Billion INR | 526.686% |
| Medicamen Biotech Limited | 160.31 Million INR | -26270.418% |
| Medico Remedies Limited | 78.67 Million INR | -53633.62% |
| Megasoft Limited | 1.28 Billion INR | -3188.548% |
| NATCO Pharma Limited | -5.81 Billion INR | 826.766% |
| RPG Life Sciences Limited | -364.7 Million INR | 11691.993% |
| Sigachi Industries Limited | 859.94 Million INR | -4816.105% |
| Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 158.336% |
| Suven Pharmaceuticals Limited | 144.97 Million INR | -29060.689% |
| Syncom Formulations (India) Limited | 46.21 Million INR | -91384.711% |
| Unichem Laboratories Limited | 931.91 Million INR | -4436.46% |
| Wanbury Limited | 1.1 Billion INR | -3722.855% |
| Windlas Biotech Limited | -273.04 Million INR | 15583.446% |
| ZIM Laboratories Limited | 983.6 Million INR | -4198.071% |
| Zydus Lifesciences Limited | 3.91 Billion INR | -980.675% |
| Sun Pharma Advanced Research Company Limited | -941.8 Million INR | 4588.851% |
| Divi's Laboratories Limited | -39.77 Billion INR | 206.301% |
| Hester Biosciences Limited | 2.29 Billion INR | -1745.517% |
| Procter & Gamble Health Limited | -2.34 Billion INR | 1900.511% |
| Amrutanjan Health Care Limited | -248.79 Million INR | 17092.508% |
| Bal Pharma Limited | 1.26 Billion INR | -3245.782% |
| Strides Pharma Science Limited | 23.25 Billion INR | -81.778% |
| Venus Remedies Limited | -267.7 Million INR | 15892.305% |
| Aarti Pharmalabs Limited | 2.61 Billion INR | -1518.592% |
| Nectar Lifesciences Limited | 6.15 Billion INR | -586.599% |
| Shilpa Medicare Limited | 9.06 Billion INR | -366.132% |
| Aarti Drugs Limited | 5.54 Billion INR | -661.949% |
| IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | 3938.736% |
| Suven Life Sciences Limited | -1.63 Billion INR | 2689.334% |
| Ind-Swift Limited | 9.5 Billion INR | -344.609% |
| Valiant Laboratories Limited | -295.03 Million INR | 14429.293% |
| J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | -1398.511% |
| Solara Active Pharma Sciences Limited | 10.02 Billion INR | -321.538% |
| Themis Medicare Limited | 764.96 Million INR | -5426.549% |
| Hikal Limited | 7.96 Billion INR | -430.639% |
| Torrent Pharmaceuticals Limited | 31.83 Billion INR | -32.818% |
| Sequent Scientific Limited | 4.17 Billion INR | -911.719% |
| Novartis India Limited | -5.89 Billion INR | 817.625% |
| Wockhardt Limited | 18.27 Billion INR | -131.396% |
| Jubilant Pharmova Limited | 27.07 Billion INR | -56.161% |
| Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | 229287.9% |
| Neuland Laboratories Limited | -214.05 Million INR | 19849.787% |
| Morepen Laboratories Limited | -231.17 Million INR | 18387.524% |
| Kilitch Drugs (India) Limited | 120.03 Million INR | -35118.554% |
| Mangalam Drugs & Organics Limited | 975.81 Million INR | -4232.396% |